Canopy(1) | $22,000,000 | (Jan 13, 2026)
Onsetto | $2,200,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
MAOLAC Capturing Nature's Wonders
Israel
- Yokneam
- 06/07/2022
- Seed
- $3,200,000
MAOLAC ingredients offer significantly better performance at lower dosages and can be integrated with food, beverage, supplement and cosmetic products.
MAOLAC combines proteomics & bioinformatics to create precision proteinsthat enable impact nutrition.
We have developed a cutting-edge proteomic discovery platform to help identify highly efficacious Functional Milk Proteins (FMPs) based on bio-similarity with breast milk, the best source of whole-body nutrition.
We build a new category of novel Functional Milk Protein mixtures (FMPs) from a variety of sources (plant base and/or bovine colostrum) in order to improve the health & wellbeing of both humans and pets.
We’ve developed a scalable platform that identifies high impact mammal-specific functional proteins and matches them with proteins found in alternative sources that have 95%+ bio similarity. Our technology also includes a unique delivery system to ensure high bioavailability and potency of the proteins.
- Industry Biotechnology
- Website https://www.maolac.com/
- LinkedIn https://www.linkedin.com/company/maolac/
Related People
Maya Ashkenazi OtmazginCo Founder
Israel -
ND
Experienced entrepreneur in the filed of R&D with a demonstrated history of working in the pharmaceuticals industry and the Start-up community. Skilled in Managing and leading a Foodtech company, Chairman- Board of Directors, experience in working with investors and clients. Extensive experience in transferring scientific and managerial presentations and Pharmaceutical Research.
M.E. Biomedical Engineering.
B.Sc. Pharmaceutical Engineering.
Cytotheryx, Inc. | $60,000,000 | (Jan 13, 2026)
MEDIPOST, Inc. | $140,000,000 | (Jan 13, 2026)
TRYBE | $30,000,000 | (Jan 13, 2026)
Kinaset Therapeutics | $103,000,000 | (Jan 13, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)
VelaFi | $20,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
Vibrant Therapeutics | $61,000,000 | (Jan 13, 2026)
Avenue Biosciences | $7,500,000 | (Jan 13, 2026)
Unusual | $3,600,000 | (Jan 13, 2026)